FIELD: medicine.
SUBSTANCE: invention relates to medicine, and is intended for treatment of varix dilatation of gullet in case of portal hypertension. Administered is detralex in dose 750-1250 mg three times per day, on the following day 750-1250 mg four times per day. Treatment course is repeated during 1-2 months.
EFFECT: method makes it possible to reduce degree of portal hypertension and edematous-ascitic syndrome.
5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS OF ALCOHOLIC AETIOLOGY | 2011 |
|
RU2477482C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CHRONIC HEPATITIS AND CIRRHOSIS AT HEPATOCEREBRAL DYSTROPHY | 2005 |
|
RU2287165C1 |
METHOD FOR PREDICTION OF PROGRESSION OF HEPATIC FAILURE IN INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2372619C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
METHOD OF DIAGNOSING CHRONIC LIVER DISEASES CAUSED BY POLYVIRAL INFECTION | 2011 |
|
RU2496426C2 |
METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
DIAGNOSTIC TECHNIQUE FOR DRUG-INDUCED LIVER INJURY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2695021C1 |
DIAGNOSTIC TECHNIQUE FOR CROSSED FORMS OF AUTOIMMUNE LIVER DISEASES | 2011 |
|
RU2477486C1 |
METHOD FOR PREDICTING PORTAL HYPERTENSION | 2004 |
|
RU2257841C1 |
Authors
Dates
2011-12-10—Published
2010-06-21—Filed